Martinez C, Hatley K, Polzien K, Diamond M, Tate D
Obes Sci Pract. 2025; 11(1):e70051.
PMID: 39911449
PMC: 11794237.
DOI: 10.1002/osp4.70051.
Li C, Guo L, Shi L, Chen L, Chen L, Xue Y
J Med Internet Res. 2024; 27:e67554.
PMID: 39694849
PMC: 11773279.
DOI: 10.2196/67554.
Dukato A, Beyamo A, Hailegebireal A, Teklehaimanot W, Ayfokru A, Alemnew M
Front Psychiatry. 2024; 15:1454087.
PMID: 39540008
PMC: 11557948.
DOI: 10.3389/fpsyt.2024.1454087.
Mulla I, Anjankar A, Pratinidhi S, Agrawal S, Gundpatil D, Lambe S
Cureus. 2024; 16(6):e63186.
PMID: 39070421
PMC: 11273947.
DOI: 10.7759/cureus.63186.
Fei L, Huang R, Li Z
Asia Pac J Clin Nutr. 2024; 33(3):313-318.
PMID: 38965720
PMC: 11389805.
DOI: 10.6133/apjcn.202409_33(3).0003.
The characterization of metabolic changes in adipose tissues and muscles due to different exercise intensities by Dixon in healthy young men.
Li L, Zhou Z, Fang J, Liu D, Deng C, Chen Y
Eur J Radiol. 2024; 177:111559.
PMID: 38865759
PMC: 11440905.
DOI: 10.1016/j.ejrad.2024.111559.
The Impact of Digital Self-Monitoring of Weight on Improving Diabetes Clinical Outcomes: Quasi-Randomized Study.
Fundoiano-Hershcovitz Y, Ritholz M, Horwitz D, Behar E, Manejwala O, Goldstein P
J Med Internet Res. 2024; 26:e54940.
PMID: 38564266
PMC: 11022133.
DOI: 10.2196/54940.
Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction.
Her A, Choi B, Rha S, Kim Y, Jeong M
Cardiovasc Diagn Ther. 2024; 14(1):38-50.
PMID: 38434553
PMC: 10904300.
DOI: 10.21037/cdt-23-349.
The impact of using reinforcement learning to personalize communication on medication adherence: findings from the REINFORCE trial.
Lauffenburger J, Yom-Tov E, Keller P, McDonnell M, Crum K, Bhatkhande G
NPJ Digit Med. 2024; 7(1):39.
PMID: 38374424
PMC: 10876539.
DOI: 10.1038/s41746-024-01028-5.
Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.
Aashish M, Arindam N, Siddiqi S, Bhosle D, Mallikarjuna V, Amol D
Clin Diabetes Endocrinol. 2024; 10(1):3.
PMID: 38336931
PMC: 10858534.
DOI: 10.1186/s40842-023-00161-6.
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data.
Shinde S, Thieu V, Kwan A, Houghton K, Meyers J, Schapiro D
Diabetes Ther. 2023; 15(2):409-426.
PMID: 38038898
PMC: 10838891.
DOI: 10.1007/s13300-023-01511-4.
The Synergism of Human and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice.
Li P, Tong T, Wu Y, Zhou X, Zhang M, Liu J
J Microbiol Biotechnol. 2023; 33(12):1657-1670.
PMID: 37734909
PMC: 10772568.
DOI: 10.4014/jmb.2304.04039.
Family Involvement to Stop the Conversion of Prediabetes to Diabetes.
Prakoso D, Mahendradhata Y, Istiono W
Korean J Fam Med. 2023; 44(6):303-310.
PMID: 37582666
PMC: 10667073.
DOI: 10.4082/kjfm.23.0019.
The Role of Natural Antioxidant Products That Optimize Redox Status in the Prevention and Management of Type 2 Diabetes.
Tuell D, Los E, Ford G, Stone W
Antioxidants (Basel). 2023; 12(6).
PMID: 37371869
PMC: 10295461.
DOI: 10.3390/antiox12061139.
Pax4 in Health and Diabetes.
Ko J, Fonseca V, Wu H
Int J Mol Sci. 2023; 24(9).
PMID: 37175989
PMC: 10179455.
DOI: 10.3390/ijms24098283.
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].
Wascher T, Paulweber B, Toplak H, Saely C, Drexel H, Foger B
Wien Klin Wochenschr. 2023; 135(Suppl 1):157-160.
PMID: 37101037
PMC: 10133339.
DOI: 10.1007/s00508-023-02166-8.
Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review.
Chadha M, Jain S, Chawla R, Dharmalingam M, Chaudhury T, Talwalkar P
Curr Diabetes Rev. 2023; 19(8):e160123212777.
PMID: 36650625
PMC: 10617785.
DOI: 10.2174/1573399819666230116150205.
Association of , , , and Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients.
Chen P, Cao Y, Chen S, Liu Z, Chen S, Guo Y
Biomedicines. 2022; 10(10).
PMID: 36289808
PMC: 9599747.
DOI: 10.3390/biomedicines10102546.
Current Advances in the Management of Diabetes Mellitus.
Aloke C, Egwu C, Aja P, Obasi N, Chukwu J, Akumadu B
Biomedicines. 2022; 10(10).
PMID: 36289697
PMC: 9599361.
DOI: 10.3390/biomedicines10102436.
Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark.
Nicolaisen S, Thomsen R, Lau C, Sorensen H, Pedersen L
BMJ Open Diabetes Res Care. 2022; 10(5).
PMID: 36113888
PMC: 9486231.
DOI: 10.1136/bmjdrc-2022-002946.
